v3.25.4
Common Stock (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Information Related to Stock Repurchase Programs

The following schedule provides information related to our stock repurchase program for each of the three years ended December 31, 2025. During 2025, 4,650,318 shares ($899.3 million in the aggregate) were repurchased pursuant to the terms of the stock repurchase program and 369,891 shares ($68.7 million in the aggregate) were repurchased in connection with the income tax withholding obligations resulting from stock-based compensation programs. During 2024, 2,982,906 shares ($598.5 million in the aggregate) were repurchased pursuant to the terms of the stock repurchase program and 375,248 shares ($72.2 million in the aggregate) were repurchased in connection with the income tax withholding obligations resulting from stock-based compensation programs. During 2023, 3,855,046 shares ($524.5 million in the aggregate) were repurchased pursuant to the terms of the stock repurchase program and 164,649 shares ($22.9 million in the aggregate) were repurchased in connection with the income tax withholding obligations resulting from stock-based compensation programs.

 

 

 

Additional
dollars
authorized
for
repurchase
(in
thousands)

 

 

Total
number of
shares
purchased (a.)

 

 

Total
number
of shares
cancelled

 

 

Average
price
paid per
share for
forfeited
restricted
shares

 

 

Total
number of
shares
purchased
as part of
publicly
announced
programs

 

 

Average
price paid
per share
for shares
purchased
as part of
publicly
announced
program

 

 

Aggregate
purchase
price paid
(in
thousands)

 

 

Aggregate
purchase
price paid
for shares
purchased
as part of
publicly
announced
program

 

 

Maximum
number of
dollars
that may
yet be
purchased
under the
program
(in
thousands)

 

Balance as of Jan. 1, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

947,368

 

2023

 

$

—

 

 

 

4,022,051

 

 

 

2,356

 

 

$

0.01

 

 

 

3,855,046

 

 

$

136.05

 

 

$

547,362

 

 

$

524,485

 

 

$

422,883

 

2024

 

$

1,000,000

 

 

 

3,358,261

 

 

 

107

 

 

$

0.01

 

 

 

2,982,906

 

 

$

200.65

 

 

$

670,753

 

 

$

598,522

 

 

$

824,361

 

2025

 

$

1,500,000

 

 

 

5,020,209

 

 

 

—

 

 

$

0.01

 

 

 

4,650,318

 

 

$

193.38

 

 

$

967,951

 

 

$

899,275

 

 

$

1,425,086

 

Total for three year
   period ended
   December 31, 2025

 

$

2,500,000

 

 

 

12,400,521

 

 

 

2,463

 

 

$

0.01

 

 

 

11,488,270

 

 

$

176.03

 

 

$

2,186,066

 

 

$

2,022,282

 

 

 

 

 

(a.)
Includes 0, 107, and 2,356, of restricted shares that were forfeited by former employees pursuant to the terms of our restricted stock purchase plan during 2025, 2024 and 2023, respectively.
Weighted-Average Assumptions Fair Value of Option Grants The weighted-average assumptions reflected below were based upon nineteen option grants for the five-year period ending

December 31, 2025, twenty-two option grants for the five-year period ending December 31, 2024 and thirty option grants for the five-year period ending December 31, 2023.

Year Ended December 31,

 

2025 (b)

 

 

2024

 

 

2023

 

Expected volatility

 

 

42

%

 

 

39

%

 

 

36

%

Risk free Interest rate

 

 

2

%

 

 

2

%

 

 

2

%

Expected life (years)

 

 

3.6

 

 

 

3.5

 

 

 

3.5

 

Forfeiture rate

 

 

7

%

 

 

7

%

 

 

7

%

Dividend yield

 

 

0.6

%

 

 

0.8

%

 

 

0.7

%

Stock Option Activity

The table below summarizes our stock option activity during the year ended December 31, 2025:

 

Outstanding Options

 

Number
of Shares

 

 

Weighted Average
Exercise
Price

 

 

Balance, January 1, 2025

 

 

3,909,248

 

 

$

124.91

 

 

Granted

 

 

—

 

 

$

—

 

 

Exercised

 

 

(1,753,871

)

 

$

117.05

 

 

Cancelled

 

 

(104,783

)

 

$

127.07

 

 

Balance, December 31, 2025

 

 

2,050,594

 

 

$

131.53

 

 

Outstanding options vested and exercisable as of
   December 31, 2025

 

 

1,013,751

 

 

$

136.92

 

 

Information about Unvested Options

The following table provides information about unvested options for the year ended December 31, 2025:

 

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Unvested options as of January 1, 2025

 

 

2,305,836

 

 

$

42.56

 

Granted

 

 

—

 

 

$

—

 

Vested

 

 

(1,165,336

)

 

$

42.10

 

Cancelled

 

 

(103,657

)

 

$

43.23

 

Unvested options as of December 31, 2025

 

 

1,036,843

 

 

$

43.01

 

Information about all Outstanding Options

The following table provides information regarding all options outstanding at December 31, 2025:

 

 

 

Options
Outstanding

 

 

Options
Exercisable

 

Number of options outstanding

 

 

2,050,594

 

 

 

1,013,751

 

Weighted average exercise price

 

$

131.53

 

 

$

136.92

 

Aggregate intrinsic value as of December 31, 2025

 

$

177,349,737

 

 

$

82,217,145

 

Weighted average remaining contractual life (years)

 

 

1.5

 

 

 

1.1

 

Weighted Average Remaining Contractual Life for Options Outstanding and Weighted Average Exercise Price Per Share for Exercisable Options

The weighted average remaining contractual life for options outstanding and weighted average exercise price per share for exercisable options at December 31, 2023, 2024 and 2025 were as follows:

 

Year Ended:

 

Options
Outstanding

 

 

Weighted
Average
Exercise
Price
Per Share

 

 

Weighted
Average
Remaining
Contractual Life
(in Years)

 

 

Exercisable
Options

 

 

Weighted
Average
Exercise Price
Per Share

 

 

Expected to
Vest
Options

 

 

Weighted
Average
Exercise Price
Per Share

 

 

 

Shares

 

 

 

 

 

 

 

 

Shares

 

 

 

 

 

Shares

 

 

 

 

2023

 

 

6,794,794

 

 

$

121.13

 

 

 

2.6

 

 

 

2,450,613

 

 

$

114.96

 

 

 

4,178,237

 

 

$

124.86

 

2024

 

 

3,909,248

 

 

 

124.91

 

 

 

2.0

 

 

 

1,603,412

 

 

 

116.94

 

 

 

1,838,407

 

 

 

130.20

 

2025

 

 

2,050,594

 

 

 

131.53

 

 

 

1.5

 

 

 

1,013,751

 

 

 

136.92

 

 

 

808,871

 

 

 

126.11